Chargement en cours...
Targeting metabolic vulnerabilities of cancer: Small molecule inhibitors in clinic
BACKGROUND: Altered cell metabolism is an established hallmark of cancer. Advancement in our understanding of dysregulated cellular metabolism has aided drastically in identifying metabolic vulnerabilities that can be exploited therapeutically. Indeed, this knowledge has led to the development of a...
Enregistré dans:
| Publié dans: | Cancer Rep (Hoboken) |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7941539/ https://ncbi.nlm.nih.gov/pubmed/32721114 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cnr2.1131 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|